Individual‐level genotyping of CYP alleles is cost prohibitive in most treatment programs in Africa; however, provider knowledge of the population distribution of CYP alleles can help guide TB‐HIV treatment in low‐resourced African settings. This evidence concerns the gene PPIG and tuberculosis.